Kidney Diseases: Medical Treatments
Commons · Question 19089 · Tabled 10 Dec 2024 · Department of Health and Social Care · Official record
Answered 16 Dec 2024
Question
Asked by Helen Morgan
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve access to SGLT2 inhibitor treatments for people with chronic kidney disease from underserved communities.
Answer
Answered by Karin Smyth, 16 Dec 2024
The National Institute for Health and Care Excellence (NICE) is the independent body responsible for developing authoritative, evidence-based recommendations for the National Health Service on whether new, licensed medicines represent a clinically and cos...